22 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
lowered CV events in T2DM ... lowered CV events in T2DM ... events in CKD + T2DM ... with or without T2DM ... with or without T2DM
Adverse Effects of Antipsychotic Medications - Comparison Table

First Generation: chlopromazine, haloperidol, fluphenazine 
Second Generation: aripirazole, asenapine,
Dyslipidemia, Weight Gain/T2DM
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
and metformin in T2D ... sulfonylurea; T2D
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Initiating Insulin for T2DM
Benzodiazepine (BZD) withdrawal: clinical findings and complications

 • Activation of ACC and OFC -> Feelings of
Cortisol -> CAD, T2DM
Type 2 Diabetes handout for patients. 
#diabetes #t2d #dm2 #low carb diet #HA1C #patient education #endocrinology
#diabetes #t2d #
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
diabetes mellitus (T2DM ... cardiovascular benefit in T2DM
The “twin cycles” of diabetes, first introduced by Roy Taylor in 2008.  
#fatty liver #fatty
pancreas #diabetes #t2d